Amanda Brandow, MD

Titles
Investigator, Children's Research Institute; assistant professor, Pediatrics, (Hematology/Oncology/BMT), the Medical College of Wisconsin.

Division
Hematology, Oncology and Transplant

Research interests
Bleeding and blood disorders, sickle cell anemia, clinical effectiveness and outcomes, health disparities, health services, pain management/palliative care

Study interests
Sickle cell disease, hydroxyurea utilization in sickle cell disease, pain evaluation and management.

Education
Medical degree, Midwestern University/Chicago College of Osteopathic Medicine; Chicago, 2001; Master of Science, Epidemiology, the Medical College of Wisconsin, Milwaukee, 2008; residency, Children's Hospital of Wisconsin, Milwaukee, 2004; fellowship, the Medical College, 2008.

Certification
Pediatrics and Pediatric Hematology/Oncology.

Honors
Pediatric Fellow Clinical Research Award, lst place, the Medical College, 2008.

Representative publications

• Kam J, Panepinto JA, Brandow AM, Brousseau DC. Parental Perception of  Hospital Care for Children with Sickle Cell Disease. Wisconsin Medical Journal. 2008; 107(3):131-135.
• Brandow AM, Brousseau DC, Panepinto JA. Post-discharge Pain, Functional Limitations and Caregiver Impact after Children with Sickle Cell Disease Seek Treatment for Vaso-occlusive Painful Events. British Journal of Haematology. 2009; 144(5):782-8.
• Brousseau DC, Mukonje T, Brandow AM, Nimmer M, Panepinto JA.  Dissatisfaction with Hospital Care for Children with Sickle Cell Disease: Not Just Race and Chronic Disease. Pediatric Blood Cancer. 2009; 53(2):174-8.
• Brandow AM, Brousseau DC, Pajewski NM, Panepinto JA. Vaso-occlusive Painful Events in Sickle Cell Disease: Impact on Child Well-being. Pediatric Blood Cancer. 2009; 54(1):92-7.
• Brandow AM, Jirovec DL, Panepinto JA. Hydroxyurea in Children with Sickle Cell Disease: Practice Patterns and Barriers to Utilization. American Journal of Hematology. In press.
• Brandow AM, Panepinto JA. Hydroxyurea Use in Sickle Cell Disease: The Battle with Low Rates of Prescription, Poor Patient Compliance and Fears of Toxicities and Side Effects. Expert Review in Hematology. In press. 2010; invited editorial review.

Grants

• Utilization and Impact of Hydroxyurea in Children with SCD, National Institutes of Health Loan Repayment Program in Pediatric Research (first renewal), principal investigator.
• Evaluation of Secondary and Tertiary Preventive Measures for Pain in Children with SCD, NIH, National Heart, Lung and Blood Institute, principal investigator, Cheryl Hillery, MD.

Contact
Children's Hospital of Wisconsin
Pediatric Hematology/Oncology/BMT
MFRC 3018
8701  Watertown Plank Road
Milwaukee, WI 53226
Phone: (414) 456-4170
Fax: (414) 456-6837
abrandow@mcw.edu